255 related articles for article (PubMed ID: 6197366)
1. Characterization of cross reacting isolates of foot & mouth disease virus.
Venkataramanan R; Mukhopadhyay AK; Rao BU
Indian J Exp Biol; 1983 Mar; 21(3):137-42. PubMed ID: 6197366
[No Abstract] [Full Text] [Related]
2. Serological behaviour of cross reacting foot & mouth disease virus isolates.
Venkataramanan R; Mukhopadhyay AK; Rao BU
Indian J Exp Biol; 1983 Mar; 21(3):134-6. PubMed ID: 6197365
[No Abstract] [Full Text] [Related]
3. [Testing of the activity of anti-foot-and-mouth disease vaccines].
Fédida M; Dannacher G; Coudert M; Perrin M; Martel JL
Dev Biol Stand; 1976; 35():243-70. PubMed ID: 198292
[No Abstract] [Full Text] [Related]
4. Immunogenicity of nanogram to milligram quantities of inactivated foot-and-mouth disease virus. II. Comparative response of guinea pigs and steers.
Morgan DO; McKercher PD; Bachrach HL
Proc Annu Meet U S Anim Health Assoc; 1968; 72():407-15. PubMed ID: 4308554
[No Abstract] [Full Text] [Related]
5. Foot-and-mouth disease circulating antibodies in convalescent cattle.
Gomes I; Fernandez AA; De Mello PA
Bull Off Int Epizoot; 1972; 77(5):731-41. PubMed ID: 4350004
[No Abstract] [Full Text] [Related]
6. Immunochemical studies of foot and mouth disease. I. Complement fixation reactions with isolated antigenic components.
Cowan KM; Trautman R
J Immunol; 1967 Oct; 99(4):729-36. PubMed ID: 4293091
[No Abstract] [Full Text] [Related]
7. Three variants of foot-and-mouth disease virus type O: cell culture characteristics and antigenic differences.
McVicar JW; Sutmoller P
Am J Vet Res; 1972 Aug; 33(8):1627-33. PubMed ID: 4340052
[No Abstract] [Full Text] [Related]
8. Isolation of variants during passage of a strain of foot-and-mouth disease virus in partly immunized cattle.
Hyslop NS; Fagg RH
J Hyg (Lond); 1965 Sep; 63(3):357-68. PubMed ID: 4283920
[No Abstract] [Full Text] [Related]
9. [Foot-and-mouth disease in Ethiopia. Distribution of serotypes of foot-and-mouth disease virus].
Martel JL
Rev Elev Med Vet Pays Trop; 1974; 27(2):169-75. PubMed ID: 4377719
[No Abstract] [Full Text] [Related]
10. The biological relevance of virus neutralisation sites for virulence and vaccine protection in the guinea pig model of foot-and-mouth disease.
Dunn CS; Samuel AR; Pullen LA; Anderson J
Virology; 1998 Jul; 247(1):51-61. PubMed ID: 9683571
[TBL] [Abstract][Full Text] [Related]
11. [Use of indirect complement fixation test for studying foot and mouth disease virus].
Tekerlekov P; Mitev G
Vet Med Nauki; 1976; 13(7):35-41. PubMed ID: 189484
[TBL] [Abstract][Full Text] [Related]
12. Escape mutants of foot-and-mouth disease virus selected by monoclonal antibodies directed to a trypsin-sensitive neutralization epitope.
Das BR; Pattnaik B; Venkataramanan R; Rai DV
Acta Virol; 1997 Jun; 41(3):131-8. PubMed ID: 9385400
[TBL] [Abstract][Full Text] [Related]
13. Immunochemical studies of foot-and-mouh disease. IX. Differences in neutralizing activities of guinea pig and bovine 19S and 7S antibodies.
Wagner GG; Cown KM
J Immunol; 1971 Mar; 106(3):656-60. PubMed ID: 4323129
[No Abstract] [Full Text] [Related]
14. Serological comparison of a type sat 2 foot-and-mouth disease virus isolate from Sudan with other type SAT 2 strains.
Abu Elzein EM; Crowther JR
Bull Anim Health Prod Afr; 1979 Dec; 27(4):245-8. PubMed ID: 232850
[No Abstract] [Full Text] [Related]
15. [Antigenic properties of strains of A 22 foot-and-mouth disease virus isolated in epizootic conditions].
Salajov EL; Antoniouk VP
Bull Off Int Epizoot; 1972; 77(5):929-34. PubMed ID: 4350008
[No Abstract] [Full Text] [Related]
16. Evidence for the persistence of foot-and-mouth disease virus in pigs.
Mezencio JM; Babcock GD; Kramer E; Brown F
Vet J; 1999 May; 157(3):213-7. PubMed ID: 10328832
[No Abstract] [Full Text] [Related]
17. [Rapid complement fixation reaction in foot-and-mouth disease].
Cherniaev IuA; Sobko AI
Veterinariia; 1974 Sep; (9):110-2. PubMed ID: 4377334
[No Abstract] [Full Text] [Related]
18. Reactions of sheep to cell-culture-modified foot-and-mouth disease virus.
Seibold HR; Dougherty E
Am J Vet Res; 1967 Jul; 28(125):1079-83. PubMed ID: 4294403
[No Abstract] [Full Text] [Related]
19. Derivatives of aziridine as inactivants for foot-and-mouth disease virus vaccines.
Warrington RE; Cunliffe HR; Bachrach HL
Am J Vet Res; 1973 Aug; 34(8):1087-91. PubMed ID: 4356910
[No Abstract] [Full Text] [Related]
20. Monoclonal antibodies to an Indian strain of type A foot-and-mouth disease virus.
Tosh C; Venkataramanan R; Pattnaik B; Hemadri D; Sanyal A
Acta Virol; 1999 Aug; 43(4):219-25. PubMed ID: 10749367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
